Skip to content

Colchicine

Colcrys, Gloperba, Mitigare (colchicine) is a small molecule pharmaceutical. Colchicine was first approved as Colcrys on 2009-07-29. It is used to treat amyloidosis, biliary liver cirrhosis, familial mediterranean fever, and gout in the USA. The pharmaceutical is active against tubulin beta chain. In addition, it is known to target glycine receptor subunit alpha-1, bromodomain-containing protein 4, and glycine receptor subunit alpha-2. Probenecid and colchicine's patents are valid until 2037-12-20 (FDA).
Trade Name Colcrys, Gloperba, Mitigare
Common Name Colchicine
Indication amyloidosis, biliary liver cirrhosis, familial mediterranean fever, gout
Drug Class
Colchicine
Get full access now